Demand Boosts European Medical Display Market

This, according to Frost & Sullivan's (Rockville, MD, USA) new research, “Medical Display Markets,” that estimates the medical display market will reach US$507 million in 2015. The research covers the following market segments: clinical, surgical, picture archiving and communication (PACS), acquisition and mammography displays. The market is forecast to grow at a compound annual growth rate of 13.6 percent from 2008 to 2012.

"Key drivers for this growth include use of displays in the cardiology PACS sector and increasing demand for displays with better image quality and features such as contrast and luminance," notes Frost & Sullivan industry analyst Dr. Gideon Praveen Kumar. "Another driver is anticipated to be the increased adoption of clinical review displays, which accounted for a share of about 42 percent of the total units shipped in 2010."

The growing sales in mammography and surgical displays will boost the market, according to the research. This increase in sales is likely to be achieved through a decrease in the average selling prices of such display units.

The demand for color images in medical equipment displays has been continuously on the rise since 2006. This has created the need for hybrid workstations offering more highly advanced functionality than conventional PACS have.

"This requires the medical displays to render color images of high contrast as well as brightness and the related software to possess postprocessing capabilities to allow 3D imaging," explains Dr. Kumar. "The mounting demand for such high-quality, color images is set to sustain market expansion."

Digitization initiatives and enhanced image quality are also factors boosting the market. Image quality is a significant factor in the choice of medical displays. Medical display manufacturers are therefore developing cutting-edge products to meet the increased demand for image quality.

The sale of high definition (HD) liquid crystal display (LCD) monitors and their use in minimally invasive procedures, such as laparoscopy and endoscopy, has been affected due to the low budgets in the majority of European hospitals. In order to boost the markets for these higher-end products efficient distribution channels must be established, as well as competitive pricing, the research concludes.

Related Links:
Frost & Sullivan